Patient Notifications

Patient notices about procedures

Microport implant recall: Profemur stemmed components

The Medicines and Healthcare Products Regulatory Agency (MHRA) have recently published a safety alert relating to hip implants supplied by Microport. The investigation found increased risks of wear and corrosion, including an increased occurrence of device fracture and revision surgery associated with cobalt chrome-containing Profemur modular neck hip stem components.

In response to this, Nuffield Health is contacting patients who we believe have been implanted with these components and invite them to an appointment with an orthopaedic surgeon to review their hip.

If you have attended a Nuffield Health hospital for hip replacement surgery and believe you received a Microport cobalt chrome-containing Profemur modular neck hip stem, you will be contacted in the coming weeks.

If our team has not been able to contact you, please contact the Nuffield Health Hospital where you had your hip surgery. They will be able to advise you if an appointment needs to be arranged.

Symbios ORIGIN® Posterior Stabilised Patient-Matched Total Knee Replacement Device

The MHRA was alerted to a significantly higher revision rate observed with the ORIGIN PS patient-matched total knee replacement. The ORIGIN PS variant demonstrates a revision rate (per 100 patient years) that is at least two times higher than all other bicondylar knee replacements in the UK.

As a precautionary measure, Symbios Orthopédie SA has initiated a voluntary suspension of all further sales and implantations, alongside a recall of all variants of the ORIGIN device family within the UK<.br>
For patients implanted with the ORIGIN PS variant, there is an increased risk of requiring an operation to replace the device.. The data shows 8 revisions from 149 primary implantations over a period of approximately 6 years. Patients have undergone revisions for aseptic loosening, malalignment, stiffness, and instability.

For patients implanted with the CR variant, there is no evidence to suggest an increased risk of revision, however the manufacturer has opted to expand the scope to include the entire ORIGIN device family as a precaution.

Nuffield Health have contacted all patients and informed them that they should return for a follow up visit within 12 months and that they will soon be invited by the NJR to complete an evaluation of their knee joint replacement.

CPT Hip System Femoral Stem 12/14 Neck Taper: Increased Risk of Postoperative Periprosthetic Femoral Fracture

The Medicines Health and Regulatory Authority (MHRA) recently published a field safety notice (FSN) relating to CPT Hip System Femoral Stem 12/14 Neck Taper Implants. Within the FSN it details that evidence shows there is an increased risk of postoperative periprosthetic femoral fracture (PFF). The risk of this complication has risen from 0.7% to 1.4%. While the risk of this fracture occurring is low, this is more than twice the risk of PFF compared to similar PTS stems that are not made of cobalt chromium.

There are no specific actions for patients already implanted with a CPT Hip System. Continue to follow the guidance and advice of your surgeon.

However following this publication, the manufacturer will cease to supply these implants in December 2024. Nuffield will no longer be implanting these devices as a precautionary measure.

Total Knee Replacement surgery using Zimmer Biomet NexGen® Stemmed Option Tibial Components

The National Joint Registry (NJR) and Zimmer Biomet (the manufacturer), have identified that the NexGen® Stemmed Option Tibial Components, when paired with either the Legacy® Posterior Stabilized (LPS) Flex Option Femoral or the LPS Flex Gender Solutions Femoral (GSF) Option Femoral, have a higher revision rate than other total knee replacements.

In response to this, Nuffield Health is contacting patients who we believe have been implanted with these combinations of components and invite them to an appointment with an orthopaedic surgeon to review their knee.

If you have attended a Nuffield Health hospital for knee replacement surgery and believe you received a Zimmer Biomet NexGen® Stemmed Option Tibial Component, you will be contacted in the coming weeks.

If our team has not been able to contact you, please contact the Nuffield Health Hospital where you had your knee surgery. They will be able to advise you if an appointment needs to be arranged. Contact details can be found here.

Patient notices about case reviews

Ms Kuldeep Stohr

Following media coverage of allegations against consultant Ms Stohr, we would like to reassure patients that their care and welfare is our priority.

If you are a former patient of Ms K Stohr, Consultant Orthopaedic Surgeon at Cambridge Nuffield Health Hospital, and you have concerns about the treatment you received, or outcomes of your procedure, please complete this form. Alternatively you can call 0300 123 1904 (09:00–17:00, Monday–Friday).

For further information, please review the Cambridge University Hospitals Independent Investigation Report (Verita Report).

Mr Marc Lamah

Following recent media coverage of allegations against consultant Mr Marc Lamah, we would like to reassure patients that the care and welfare of our patients is our priority and a review of a number of Mr Lamah’s patients is currently ongoing.

Whilst we cannot comment about the care of individual patients for confidentiality reasons, we will provide support as appropriate.

If you were a patient of Mr Lamah and are concerned about the treatment you received, you can contact the customer relations team by email: customer.relations@nuffieldhealth.com

 For further information, please email us revalidation@nuffieldhealth.com